BiotechTube
Home/Polygon Therapeutics/Mohamed Abou Ali
MA

Mohamed Abou Ali

Chief Executive Officer & Co-founder

Polygon Therapeutics

Therapeutic Areas

CardiovascularImmunology

Polygon Therapeutics Pipeline

DrugIndicationPhase
PLG-101 (EMOTION Program)Acute Myocardial Infarction (Heart Attack)Pre-clinical

Leadership Team at Polygon Therapeutics

PH
Pr. Hafid Ait Oufella
Chief Scientific Officer & Co-founder
TM
Tatiana Monseur
Chief Operating & Financial Officer & Co-founder
PP
Prof. Peter Libby
Scientific Board Member
PN
Prof. Nicolas Danchin
Scientific Board Member
View full Polygon Therapeutics profile